Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-03

Clinical Trial Update: A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer

View source ↗

Summary

This document reports a clinical trial evaluating nivolumab in combination with chemotherapy as first-line treatment for adults with advanced or metastatic gast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (unspecified)
  • nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Gastric Cancer | Status: ACTIVE_NOT_RECRUITING